abstract |
The present invention discloses monospecific and bispecific molecules comprising EGFR and/or c-Met FN3 domains, isolated polynucleotides encoding said molecules, vectors, host cells, and methods for their preparation. These monospecific and bispecific molecules comprising EGFR and/or c-Met FN3 domains can be used to generate therapeutic compositions for the treatment and diagnosis of disorders and diseases including cancer. |